Epistemis

Frothy urine

Specialty: Nephrology and urology.

  • macroscopic proteinuria
  • persistent foam in the urine

Why it occurs

  • Nephrotic syndrome (glomerulopathies such as membranous nephropathy, minimal change disease or focal segmental glomerulosclerosis with massive albumin loss)
  • Diabetic nephropathy (advanced glomerular microvascular damage with micro and macroalbuminuria)
  • Lupus glomerulonephritis (deposition of immune complexes in the glomerulus due to the activity of systemic lupus erythematosus)
  • Renal amyloidosis (extracellular deposition of amyloid fibrils that disrupt the glomerular filtration barrier)
  • Malignant arterial hypertension (glomerular endothelial damage induced by extremely high systemic pressures)

Initial workup

Urine test strip for semi-quantification of proteins; 24-hour urine collection to quantify total protein and creatinine clearance, or determination of the protein/creatinine ratio (UPCR) or albumin/creatinine ratio (UACR) in an isolated first morning urine sample; serum quantification of albumin, total proteins and lipid profile; Ultrasound-guided percutaneous renal biopsy for definitive histopathological diagnosis if nephrotic range proteinuria (>3.5 g/24h) without obvious systemic cause is confirmed.

red flags

Frothy urine that is accompanied by edema of the eyelids, face or lower limbs with rapid progression towards anasarca, dyspnea when lying down (orthopnea due to pleural effusion or associated heart failure), or uncontrolled blood pressure levels (>180/120 mmHg).

Standard management

  • Enalapril — 5-20 mg every 12 hours orally, ACE inhibitor to reduce intraglomerular pressure through vasodilation of the efferent arteriole, reducing proteinuria; monitor potassium and creatinine) or Losartan (50-100 mg daily, angiotensin II receptor antagonist as an alternative if you have cough due to ACE inhibitors
  • Furosemide — 20-80 mg daily orally for the management of edema, adjusting according to fluid balance
  • Atorvastatin (20-40 mg daily for the management of hypercholesterolemia secondary to nephrotic syndrome).

Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.

Area
Nephrology and urology
Listed causes
5
Treatment options
3
Download Epistemis